Breast cancer risk by the extent and type of atypical hyperplasia
Cancer
.
2016 Oct;122(19):3087-8.
doi: 10.1002/cncr.30151.
Epub 2016 Jun 28.
Authors
Amy C Degnim
1
,
Daniel W Visscher
2
,
Derek C Radisky
3
,
Marlene H Frost
4
,
Robert A Vierkant
5
,
Ryan D Frank
6
,
Stacey J Winham
5
,
Celine M Vachon
7
,
William D Dupont
8
,
Lynn C Hartmann
4
Affiliations
1
Division of Subspecialty General Surgery, Mayo Clinic, Rochester, Minnesota.
2
Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota.
3
Cancer Biology, Mayo Clinic, Jacksonville, Florida.
4
Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.
5
Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.
6
Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, Florida.
7
Division of Epidemiology, Mayo Clinic, Rochester, Minnesota.
8
Department of Biostatistics, Vanderbilt University, Nashville, Tennessee.
PMID:
27352099
PMCID:
PMC5577812
DOI:
10.1002/cncr.30151
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Breast Neoplasms
Breast*
Humans
Hyperplasia*
Precancerous Conditions
Risk
Risk Factors
Grants and funding
R21 CA186734/CA/NCI NIH HHS/United States
P50 CA098131/CA/NCI NIH HHS/United States
P50 CA116201/CA/NCI NIH HHS/United States
P30 CA015083/CA/NCI NIH HHS/United States
P30 CA068485/CA/NCI NIH HHS/United States
R01 CA187112/CA/NCI NIH HHS/United States
R01 CA050468/CA/NCI NIH HHS/United States